Drugs / AZD8566
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00866385 | Mar 2009 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT00844103 | Jan → Apr 2009 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT00749333 | Aug 2008 → Feb 2009 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD8566 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00844103 ↗ |
| Route | Oral | “Single Oral Doses of AZD8566” NCT00749333 ↗ |